Published in Archives

The FDA has approved the EVO Visian ICL.

This is editorially independent content
1 min read

Can you refresh me on ICL's?

Sure! ICL stands for Implantable Collamer Lens. The lens is inserted between the iris and natural lens of the eye and is a great option for patients who are not candidates for photorefractive keratectomy (PRK) or LASIK.

Here is a more detailed rundown.

Tell me more about the EVO Visian ICL?

EVO Visian ICL (Staar Surgical) is indicated for use in phakic eye treatment in patients 21–45 years of age:

  • for the correction/reduction of myopia in patients with spherical equivalent ranging from -3.0 D to -20.0 D at the spectacle plane;
  • for the correction/reduction of myopic astigmatism in patients with spherical equivalent ranging from -3.0 D to -20.0 D with cylinder of 1.0 D to 4.0 D at the spectacle plane;
  • with an anterior chamber depth (ACD) of 3.00 mm or greater, when measured from the corneal endothelium to the anterior surface of the crystalline lens;
  • and a stable refractive history (within 0.5 D for 1 year prior to implantation).

Anything else?

Ask Joe Jonas.

How would you rate the quality of this content?